Clinical Trials Browser

Interventional × mogamulizumab × Tumor-Agnostic × Clear all

NCT02867007 2024-04-25

KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Carcinoma, Neoplasms